JSM Activity #31

This is the preliminary program for the 2003 Joint Statistical Meetings in San Francisco, California. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 2-5, 2003); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2003 Program page
Legend: = Applied Session, = Theme Session, = Presenter
Hotels: H = Hilton San Francisco, R = Reniassance Parc Hotel 55, N = Nikko San Francisco
Add To My Program
31 Applied Session Sun, 8/3/03, 2:00 PM - 3:50 PM H-Continental Ballroom 2 & 3
Power Estimates and Sample Size Determination - Contributed - Papers
Biopharmaceutical Section
Chair(s): Mathew D. Austin, Amgen, Inc.
     2:05 PM   Calculation of Sample Size in Survival Trials: The Impact of Informative Noncompliance — Qi Jiang, Merck Research Laboratories; Steven M. Snapinn, Merck & Co., Inc.; Boris Iglewicz, Temple University
     2:20 PM   Sample Size Determination for Nonlinear Models — Mohammad K. Alam, North Dakota State University; Thomas E. Bradstreet, Merck Research Laboratories; Marepalli B. Rao, North Dakota State University
     2:35 PM   Approximating the Power and Size for Simultaneous Statistical Tests of a Binary Endpoint Using the Delta Method with Specific Application to the Cochran-Mantel-Haenszel Test — Jason B. Clark, Centocor, Inc.
     2:50 PM   Designs, Power, and Sample Size for a NonStop Drug Development Strategy — John D. Johnson, Rho, Inc.
     3:05 PM   Sample Size and Power Analysis for Endometrial Safety Studies — Guoqin Su
     3:20 PM   Comparison of Two Sample Size Adjustment Procedures in Clinical Trials — Chenxiong Le, Food and Drug Administration; Hsien-Ming James Hung, Food and Drug Administration
     3:35 PM   Floor Discussion
 

JSM 2003 For information, contact meetings@amstat.org or phone (703) 684-1221. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2003